NCT01815138View on ClinicalTrials.gov

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

PHASE4CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

October 31, 2016

Conditions
Ovarian Hyperstimulation Syndrome
Interventions
DRUG

hCG

Adjuvant low dose hCG 1,000 IU administered at the time of GnRH agonist trigger

DRUG

hCG

Adjuvant low dose hCG 1,500 IU administered 35 hours after GnRH agonist trigger

Trial Locations (1)

06030

University of Connecticut Health Center, Farmington

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

UConn Health

OTHER

NCT01815138 - Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS | Biotech Hunter | Biotech Hunter